Milestone Pharmaceuticals (MIST) EBT: 2020-2021
Historic EBT for Milestone Pharmaceuticals (MIST) over the last 2 years, with Dec 2021 value amounting to -$42.9 million.
- Milestone Pharmaceuticals' EBT fell 2.33% to -$14.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$58.2 million, marking a year-over-year change of. This contributed to the annual value of -$42.9 million for FY2021, which is 14.27% up from last year.
- Latest data reveals that Milestone Pharmaceuticals reported EBT of -$42.9 million as of FY2021, which was up 14.27% from -$50.0 million recorded in FY2020.
- Over the past 5 years, Milestone Pharmaceuticals' EBT peaked at -$42.9 million during FY2021, and registered a low of -$50.0 million during FY2020.
- Moreover, its 2-year median value for EBT was -$46.4 million (2020), whereas its average is -$46.4 million.
- Data for Milestone Pharmaceuticals' EBT shows a peak YoY climbed of 14.27% (in 2021) over the last 5 years.
- Milestone Pharmaceuticals' EBT (Yearly) stood at -$50.0 million in 2020, then increased by 14.27% to -$42.9 million in 2021.